organization · Reporting owner
Squadron Capital LLC
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphatec Holdings, Inc.ATEC · Entity 4720 | 10% owner | December 08, 2025 | December 11, 2025 |
| ORTHOPEDIATRICS CORPKIDS · Entity 5338 | 10% owner | September 10, 2026 | September 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphatec Holdings, Inc.
Report date December 08, 2025 · Filed December 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,645,045 |
Ending reported balance
After 2025-12-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-12-08 · Sale · Disposed 221,166 · Balance 10,673,879 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Row 2 · 2025-12-09 · Sale · Disposed 28,834 · Balance 10,645,045 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
ORTHOPEDIATRICS CORP
Report date September 10, 2026 · Filed September 11, 2026
Jointly reported with Squadron Capital Holdings LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,201,764 |
Reported balance
After 2026-09-10 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-09-10 · Sale · Disposed 302,369 · Balance 6,201,764 F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 11, 2026 12:30 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 302,369 | $21.01 | $6,352,772.69 |
DisclosureSEC source: 0001193125-26-388667 · ownership.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,201,764 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:42 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 22,500 | $23.35 | $525,375.00 |
DisclosureSEC source: 0001193125-26-383761 · ownership.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,504,133 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 22:48 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 10,131 | $23.10 | $234,026.10 |
DisclosureSEC source: 0001193125-26-378892 · ownership.xml · nonDerivative · entry 2 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,526,633 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 22:48 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 326,700 | $23.04 | $7,527,168.00 |
DisclosureSEC source: 0001193125-26-378892 · ownership.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,536,764 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| August 26, 2026 Filed Aug 26, 2026 22:29 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 18,000 | $24.28 | $437,040.00 |
DisclosureSEC source: 0001193125-26-369063 · ownership.xml · nonDerivative · entry 3 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,863,464 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 22:29 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 16,300 | $24.74 | $403,262.00 |
DisclosureSEC source: 0001193125-26-369063 · ownership.xml · nonDerivative · entry 2 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,881,464 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 22:29 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 4,000 | $25.75 | $103,000.00 |
DisclosureSEC source: 0001193125-26-369063 · ownership.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,897,764 F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 00:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 28,834 | $21.03 | $606,379.02 |
DisclosureSEC source: 0001719228-25-000009 · form4-12102025_071208.xml · nonDerivative · entry 2 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,645,045 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 221,166 | $21.20 | $4,688,719.20 |
DisclosureSEC source: 0001719228-25-000009 · form4-12102025_071208.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,673,879 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 00:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 250,000 | $20.62 | $5,155,000.00 |
DisclosureSEC source: 0001719228-25-000007 · form4-11252025_071101.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,895,045 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.34 to $20.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:33 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 250,000 | $20.80 | $5,200,000.00 |
DisclosureSEC source: 0001719228-25-000005 · form4-11142025_091148.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,145,045 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.67 to $21.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:34 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | OtherWarrants (right to buy) · Derivative | 1,525,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-031660 · doc4.xml · derivative · entry 2 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F1 · derivative.exercise_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F1 · derivative.expiration_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days. F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 11:34 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | OtherCommon Stock | 1,525,000 | $0.00 | $457.50 |
DisclosureSEC source: 0000899243-22-031660 · doc4.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,901,764 F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:38 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | PurchaseWarrants (right to buy) · Derivative | 1,525,000 | $55.00 Strike: $0.00 | $83,874,695.00 |
DisclosureSEC source: 0000899243-22-028658 · doc4.xml · derivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,525,000 Underlying: Common Stock · 1,525,000 shares Expires not disclosed F1 · derivative.exercise_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron Capital LLC is obligated to exercise them within five (5) business days. F1 · derivative.expiration_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron Capital LLC is obligated to exercise them within five (5) business days. F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. Read SEC document |
| June 19, 2020 Filed Jun 22, 2020 19:21 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,340 | $30.97 Strike: $30.97 | $41,499.80 |
DisclosureSEC source: 0001425450-20-000092 · wf-form4_159285368059079.xml · derivative · entry 2 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,340 shares Expires 2022-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| June 19, 2020 Filed Jun 22, 2020 19:21 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 1,340 | $30.97 | $41,499.80 |
DisclosureSEC source: 0001425450-20-000092 · wf-form4_159285368059079.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,376,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 22:07 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | ConversionSeries B Convertible Preferred Stock · Derivative | 4,157,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-052691 · tv477024_4.xml · derivative · entry 4 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,785,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). F3 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). F3 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 22:07 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | ConversionSeries A Convertible Preferred Stock · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-052691 · tv477024_4.xml · derivative · entry 3 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 670,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). F3 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). F3 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 22:07 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | ConversionCommon Stock | 1,920,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-052691 · tv477024_4.xml · nonDerivative · entry 2 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,378,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares received upon conversion of a $16.0 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering. F3 · price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 22:07 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | ConversionCommon Stock | 3,455,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-052691 · tv477024_4.xml · nonDerivative · entry 1 Squadron Capital LLC · CIK 0001719228 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares received upon conversion of the Series A Convertible Preferred Stock and the Series B Convertible Preferred Stock immediately prior to the completion of the Issuer's initial public offering. F3 · price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into approximately 0.67 shares of Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering. In connection with the conversion of the Series A Convertible Preferred Stock into Common Stock, a $16.00 million preference payment, and approximately $8.96 million of accrued and unpaid dividends, on the Series A Convertible Preferred Stock converted into 1,920,062 shares of Common Stock for no additional consideration at a conversion price of $13.00 per share (the initial public offering price of the Common Stock). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.